|Articles|March 1, 2001

March 2001
Volume 7
Issue 3

Clinical and Economic Outcomes of an Ambulatory Urinary Tract Infection Disease Management Program

Author(s)Edward P. Armstrong, PharmD

Download PDF: Clinical and Economic Outcomes of an Ambulatory Urinary Tract Infection Disease Management Program

Articles in this issue

almost 25 years ago

Article

Prior-Authorization Requirements for Patient Referrals to Specialists

almost 25 years ago

Article

Assessing Safety of New Technology: Conference Looks at Evaluation Process

almost 25 years ago

Article

Physician Perceptions of a National Formulary

almost 25 years ago

Article

Specialty of Principal Care Physician and Medicare Expenditures in Patients with Coronary Artery Disease:Impact of Comorbidity and Severity

almost 25 years ago

Article

Renal Effects of Angiotensin-Converting Enzyme Inhibitors That Result in Cost Savings and Improved Patient Outcomes

almost 25 years ago

Article

Are Patients' Chief Complaints Generally Specific to One Organ System?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Clinical and Economic Outcomes of an Ambulatory Urinary Tract Infection Disease Management Program

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD